Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Stewart Mearns MPS[/caption]
Zara Gul[/caption]
References
- Chaing HC, Huang V, Cornelius LA. Cancer and itch. Seminars in cutaneous medicine and surgery 2011;30(2):107–12.
- Weisshaar E, Dalgard F. Epidemiology of itch: adding the burden of skin morbidity. Acta Dermato-Venereologica 2009;89:339–50.
- Boehlke C, Joos L, Coune B, et al. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database of Systematic Reviews 2024, Issue 8.
- Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. New Engl J Med 2013;368(17):1625–34.
- Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010;49(1):1–11.
- Xander C, Meerpohl J, Galandi D, et al. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database of Systematic Reviews 2013, Issue 6.
- Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease. Cochrane Database of Systematic Reviews 2020, Issue 12.
